In a landmark development in the False Claims Act (FCA) legal landscape, AZ Diabetic and its owner, Hisham Zaghal, are facing a hefty $12 million default judgment for purchasing prescription drugs illegally. The verdict underscores the severe implications of neglecting to file an appearance in an FCA case.
As reported by legal news site JD Supra, the U.S. Government initiated the lawsuit in late August 2022 in the Eastern District of Virginia, alleging that Zaghal’s operations violated the FCA. The allegations were particularly centered on reimbursement claims totalling over $600,000, related to prescriptions that AZ Diabetic had illicitly procured.
The fallout from this development is multi-faceted. Firstly, there is the significant financial burden imposed by the default judgment. But arguably more crucial is the signaling effect that such a development has within the legal and corporate world. Even beyond the tangible financial implications, this serves as a stark reminder to law firms and corporations of the strategic importance of filing an appearance in an FCA case, highlighting the potential for severe consequences when this step is overlooked.
While it is up to the courts to ultimately decide the fate of AZ Diabetic and Zaghal, legal professionals and corporate legal departments would do well to heed the lesson from this case. Vigilant observance of due process and meticulous adherence to FCA provisions can be a strong bulwark against similar costly sanctions.